Pleased to share our perspective article entitled "An AI‐first framework for multimodal data in Alzheimer's disease and related dementias" - Alzheimer's & Dementia - alz-journals.onlinelibrary.wiley.com/doi/10.1002/... @alzdemjournals.bsky.social @istaart.bsky.social

Our new paper in Human Brain Mapping presents an anatomy-guided, modality-agnostic framework to assess disease-related abnormalities in brain MRI. Please check it out! doi.org/10.1002/hbm.... @bostonu.bsky.social

A new AI tool designed by researchers at Boston University helps to accurately predict biomarkers of Alzheimer’s disease. To learn more, click here: bit.ly/4mfrUpK

A nice video summary of our paper entitled "Multimodal deep learning for Alzheimer’s disease dementia assessment", published in Nature Communications (2022). @natcomms.nature.com youtu.be/ZvkC0XpmKFY Source: @notebooklm.bsky.social

The Kolachama Lab is tackling the PET scan bottleneck in Alzheimer’s diagnosis with an AI model that predicts amyloid-β & tau status from 12,185 patients across 7 cohorts, offering a scalable alternative for pre-screening & guiding PET imaging. www.nature.com/articles/s41...

A nice video summary of our paper entitled "Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification", published in Brain (2020). youtu.be/quwlODDgtgQ Source: @notebooklm.bsky.social

Delighted that our latest work is now online @natcomms.nature.com!! 🧠🔬 We built an AI model that can predict Alzheimer's disease biomarkers (Aβ and τ) using widely available clinical data. This could make it much easier to screen for AD without PET scans. Link here: www.nature.com/articles/s41...

🔬 Meet PodGPT – your AI partner for medical & STEM breakthroughs! Link to the paper: www.nature.com/articles/s44... 💡 Ask it anything: "How does CRISPR work?" "Explain AI in diagnostics" "What’s the future of gene editing?" #AI #Medicine #STEM #PodGPT 👉 Got a question? Click here: podgpt.org 🌱